Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Aveanna (NASDAQ: AVAH) announced that management will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and will present on January 14, 2026.
The presentation is scheduled for 9:45 a.m. PST on January 14, 2026, followed by one-on-one investor meetings the same day. Interested parties can listen via a simultaneous webcast at https://ir.aveanna.com/. An online replay will be available for a limited time shortly after the call.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AVAH gained 1.57%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers showed mixed moves: NHC +1.72%, ARDT +0.68%, BKD +0.67%, PIII +0.66%, while SEM fell -1.57%. With AVAH down -0.56% and no momentum scanner signals, trading appeared more stock-specific than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Conference participation | Neutral | +2.1% | Announcement of BofA home care conference appearance and webcast access. |
| Nov 06 | Earnings update | Positive | -6.3% | Strong Q3 growth, positive net income, raised 2025 guidance and liquidity detail. |
| Oct 21 | Secondary offering | Negative | -0.4% | Pricing of 10M-share secondary by existing holders at $9.00 per share. |
| Oct 21 | Secondary launch | Negative | -0.4% | Launch of 10M-share secondary and 30-day option for 1.5M additional shares. |
| Oct 21 | Prelim earnings | Positive | -0.4% | Preliminary Q3 results showing strong revenue, net income and EBITDA growth. |
Recent earnings with strong growth and raised guidance saw negative price reactions, while conference participation and secondary offerings drew mild moves, suggesting occasional divergence between fundamentals-focused news and short-term trading.
Over the last few months, Aveanna reported strong fundamentals: Q3 2025 revenue of $621.9M and net income of $14.1M, with guidance raised to revenue above $2.375B and Adjusted EBITDA above $300M. Despite this, the stock fell 6.3% on that earnings release. October brought a secondary offering by existing holders at $9.00 per share with minimal price impact around -0.39%. Participation in the BofA Home Care Conference on Dec 9, 2025 coincided with a modest +2.14% move, similar in nature to today’s J.P. Morgan conference appearance.
Market Pulse Summary
This announcement highlights Aveanna’s participation in the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with a scheduled 9:45 a.m. PST presentation and webcast replay. It follows a period of strong reported revenue growth, raised guidance, and secondary offerings by existing shareholders. Investors may focus on how management uses this forum to reiterate strategy and financial priorities, and how messaging aligns with recent SEC filings and prior conference communications accessible via the Investor Relations website.
AI-generated analysis. Not financial advice.
ATLANTA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026.
Management will present at 9:45 a.m. PST followed by 1x1 investor meetings on the same day, January 14, 2026. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.
About Aveanna Healthcare
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.
Investor Contact Matt Buckhalter Chief Financial Officer ir@aveanna.com
FAQ
When will Aveanna (AVAH) present at the J.P. Morgan Healthcare Conference?
How can investors watch the Aveanna (AVAH) presentation on January 14, 2026?
Will Aveanna (AVAH) hold investor meetings at the 44th J.P. Morgan Healthcare Conference?
Is there a replay of the Aveanna (AVAH) conference presentation and how long will it be available?
Where is the 44th Annual J.P. Morgan Healthcare Conference where Aveanna (AVAH) will present?
What time zone is used for Aveanna's (AVAH) January 14, 2026 presentation time?
